Come up with a name for your new list and we'll add to it:
InSphero raised a round of funding on March 27, 2012. Investors include
Swiss Commission of Technology and Innovation.
InSphero is biotech company focusing on industrial-grade, 3D-cell-based assay solutions and 3D organ-on-a-chip technology. Through partnerships, InSphero supports pharmaceutical and biotechnology res…